| Nicole M Candelario, MD | |
|
Professional Center, #2 Luis Munoz Rivera St. Suite 201, Caguas, PR 00725 | |
| (787) 744-5353 | |
| (787) 961-1189 |
| Full Name | Nicole M Candelario |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 14 Years |
| Location | Professional Center, Caguas, Puerto Rico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215243829 | NPI | - | NPPES |
| IR688A | Other | PR | PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 19349 (Puerto Rico) | Primary |
| Entity Name | Laboratorio De Patologia Dr Noy |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225016140 PECOS PAC ID: 8325062714 Enrollment ID: O20060125000021 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited received final approval on July 20 from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Minocycline Hydrochloride Extended Release Tablets (Minocycline ER), 45 mg, 90 mg and 135 mg, the generic version of Solodyn® ER, a treatment for acne, sold by Medicis Pharmaceuticals Corporation (Medicis). Mylan Pharmaceuticals Inc. commenced immediate shipment of the product after approval.
The study suggests that age is a factor in estrogen treatment and sheds light on the intricate relationship between mind, age, and hormones. The study will be published in the online edition of Proceedings of the National Academy of Sciences during the week of June 25.
Arthritis & Osteoporosis NSW has recently launched the Juvenile Arthritis Campaign aimed at raising much needed awareness and funds for the thousands of children struggling with arthritis throughout NSW. More than 6,000 children live with the condition and there are many more yet to be diagnosed.
Colon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to adapt to the lack of oxygen and nutrients inside the tumor. Statins, which are often prescribed to lower cholesterol, block this metabolic pathway and cause the cancer cells to die, as scientists from the German Cancer Research Center have now discovered.
› Verified 6 days ago
| Entity Name | B Derm Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194278689 PECOS PAC ID: 9133458201 Enrollment ID: O20190916001058 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited received final approval on July 20 from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Minocycline Hydrochloride Extended Release Tablets (Minocycline ER), 45 mg, 90 mg and 135 mg, the generic version of Solodyn® ER, a treatment for acne, sold by Medicis Pharmaceuticals Corporation (Medicis). Mylan Pharmaceuticals Inc. commenced immediate shipment of the product after approval.
The study suggests that age is a factor in estrogen treatment and sheds light on the intricate relationship between mind, age, and hormones. The study will be published in the online edition of Proceedings of the National Academy of Sciences during the week of June 25.
Arthritis & Osteoporosis NSW has recently launched the Juvenile Arthritis Campaign aimed at raising much needed awareness and funds for the thousands of children struggling with arthritis throughout NSW. More than 6,000 children live with the condition and there are many more yet to be diagnosed.
Colon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to adapt to the lack of oxygen and nutrients inside the tumor. Statins, which are often prescribed to lower cholesterol, block this metabolic pathway and cause the cancer cells to die, as scientists from the German Cancer Research Center have now discovered.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicole M Candelario, MD P.o. Box 1176, Caguas, PR 00726 Ph: (787) 703-1525 | Nicole M Candelario, MD Professional Center, #2 Luis Munoz Rivera St. Suite 201, Caguas, PR 00725 Ph: (787) 744-5353 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited received final approval on July 20 from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Minocycline Hydrochloride Extended Release Tablets (Minocycline ER), 45 mg, 90 mg and 135 mg, the generic version of Solodyn® ER, a treatment for acne, sold by Medicis Pharmaceuticals Corporation (Medicis). Mylan Pharmaceuticals Inc. commenced immediate shipment of the product after approval.
The study suggests that age is a factor in estrogen treatment and sheds light on the intricate relationship between mind, age, and hormones. The study will be published in the online edition of Proceedings of the National Academy of Sciences during the week of June 25.
Arthritis & Osteoporosis NSW has recently launched the Juvenile Arthritis Campaign aimed at raising much needed awareness and funds for the thousands of children struggling with arthritis throughout NSW. More than 6,000 children live with the condition and there are many more yet to be diagnosed.
Colon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to adapt to the lack of oxygen and nutrients inside the tumor. Statins, which are often prescribed to lower cholesterol, block this metabolic pathway and cause the cancer cells to die, as scientists from the German Cancer Research Center have now discovered.
› Verified 6 days ago
Dr. Jose A Rabelo, Dermatology Medicare: Not Enrolled in Medicare Practice Location: Suite 209 Catalinas Cinemas Office Center, Caguas, PR 00725 Phone: 787-263-1001 | |
Dr. Luz D. Figueroa - Guzman, MD Dermatology Medicare: Medicare Enrolled Practice Location: 2 Calle Munoz Rivera, Professional Center Suite 309, Caguas, PR 00725 Phone: 787-746-6764 Fax: 787-746-6764 | |
Samuel Sanchez Rivera, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 200 Grand Boulevard Los Prados, Plaza Los Prados Suite Z-5, Caguas, PR 00727 Phone: 787-746-3136 Fax: 787-745-1585 | |
Dr. Rachelle E. Seijo, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: Ave Jose Garrido, Catalinas Cinema Building Suite 209, Caguas, PR 00725 Phone: 787-626-3431 Fax: 787-626-5163 | |
Mariana Cruz Manzano, M.D Dermatology Medicare: Accepting Medicare Assignments Practice Location: Plaza Los Prados Suite Z-5, 200 Grand Boulevard Los Prados, Caguas, PR 00727 Phone: 787-746-3136 Fax: 787-745-1585 | |
Tania Marie Gonzalez Santiago, M.D Dermatology Medicare: Accepting Medicare Assignments Practice Location: 201 Ave Gautier Benitez, Ste 405a Consolidated Medical Mall, Caguas, PR 00726 Phone: 787-346-3376 |